Pharmaco-Economic Evaluation of the Treatment used in Ophthalmological Practice

Authors

  • Shoyusuf F. Shodmanov

  • Shakhnoza Z. Umarova

Keywords:

pharmacoeconomic evaluation, ophthalmology, medicines, relative risk, probabilities of events, cost-effectiveness analysis

Abstract

The most important among the clinical forms of glaucoma is primary open-angle glaucoma (POAG), which, according to various authors, occurs in 70%-92% of cases. Due to the high prevalence of POAG, late detection and serious prognosis for visual functions, this disease occupies a special place in clinical ophthalmology. The aim of the study is to conduct a pharmacoeconomic evaluation of Tafluprostvs Travoprost in patients with POAG. Materials and methods of research is pharmacoeconomic methods of analysis, in particular the calculation of the relative risk, the calculation of the probability of events, cost-effectiveness analysis. According to the calculated results of pharmacoeconomic analyzes, Tafluprost was relatively less expensive and more clinically effective than Travoprost in patients with primary open-angle glaucoma. Alternative treatment with Tafluprost contributes to savings in the overall treatment procedure. Therefore, we recommend adding Tafluprost to the list of essential medicines.

Downloads

How to Cite

Shoyusuf F. Shodmanov, & Shakhnoza Z. Umarova. (2022). Pharmaco-Economic Evaluation of the Treatment used in Ophthalmological Practice. Global Journal of Medical Research, 22(B2), 5–11. Retrieved from https://medicalresearchjournal.org/index.php/GJMR/article/view/2684

Pharmaco-Economic Evaluation of the Treatment used in Ophthalmological Practice

Published

2022-04-08